Eppin Pharma
Eppin Pharma is a private Durham, North Carolina-based pharmaceutical company developing a single non-hormonal oral male contraceptive pill currently in early proof-of-concept clinical trials, targeting men of reproductive age.
- Company typePrivate
- Founded2001
- HeadquartersDurham, United States
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
Eppin Pharma firmographics
Firmographics- Name
- Eppin Pharma
- Website
- https://eppinpharmainc.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Eppin Pharma is a private Durham, North Carolina-based pharmaceutical company developing a single non-hormonal oral male contraceptive pill currently in early proof-of-concept clinical trials, targeting men of reproductive age.
- Ownership category
- akta.pro rank
Eppin Pharma industry classification
Industry- Product category
- Reproductive Health Pharmaceuticals (Male Contraceptives)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)
Keywords
Where Eppin Pharma is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Markets served
Eppin Pharma business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
Revenue model
- Pharmaceutical product revenue (future): Pre-revenue company developing a non-hormonal male contraceptive pill. Revenue model will be through pharmaceutical product sales following regulatory approval and commercialization.
Eppin Pharma product offering
Product offeringCore offering
Eppin Pharma is developing a novel non-hormonal, orally administered male contraceptive pill intended to provide reversible male birth control without hormonal intervention. The product is in early clinical development, with current activities focused on proof-of-concept studies for safety and feasibility to support future larger efficacy trials and regulatory approval.
Differentiator
Problem solved
Functional benefit
Products and services
- Non-hormonal Male Contraceptive Pill A novel non-hormonal male contraceptive pill designed to provide reversible male birth control without hormonal intervention. The product is intended for men of reproductive age seeking non-hormonal contraceptive options and is currently in clinical trials to establish proof-of-concept for safety and feasibility before larger efficacy studies for regulatory approval.
Companies that use Eppin Pharma
Customer profileSegments1 record
Ideal customer profiles1 record
Eppin Pharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Eppin Pharma partnerships and signals
Strategic signalScale indicators1 record
Eppin Pharma competitors and assessment
Company assessmentDirect peers
- Contraline: Contraline is developing a non-hormonal, long-acting male contraceptive (ADAM hydrogel/Vasalgel). It is the most direct competitor to Eppin Pharma, sharing the non-hormonal mechanism and male contraceptive target, with a different delivery format.
- YourChoice Therapeutics: YourChoice Therapeutics is developing a non-hormonal contraceptive for men, working on a reversible, on-demand male birth control method. It competes for the same end users and unmet need that Eppin Pharma is targeting.
- NEXT Life Sciences: NEXT Life Sciences (formerly known as Plan A) is developing a non-hormonal, reversible male contraceptive. It pursues the same target market as Eppin Pharma — men seeking reversible contraception without hormonal intervention — making it a close direct peer.
Broad incumbents
- Evofem Biosciences: Evofem Biosciences develops and commercializes products in women's sexual and reproductive health, including hormone-free contraceptives. Its hormone-free positioning mirrors Eppin Pharma's non-hormonal differentiation strategy in the reproductive health space.
- Cosette Pharmaceuticals: Cosette Pharmaceuticals is a specialty pharmaceutical company with a portfolio including women's health and contraceptive products. As a broader reproductive health pharma player, it represents a comparable business model and potential commercialization partner.
- Bayer (Pharmaceuticals Division): Bayer's pharmaceutical division has historically been a major player in contraception (e.g., Yaz, Mirena). As a global incumbent in hormonal and device-based contraception, it represents both a potential acquirer and a competitor for the male contraceptive market Eppin Pharma is targeting.
- Merck & Co. Merck has previously invested in male contraceptive research programs and remains a global pharmaceutical incumbent. Its historical interest in male contraception makes it a relevant comparable for the broader R&D direction Eppin Pharma is pursuing.
- Organon: Organon is a global women's health company spun out of Merck that markets multiple contraceptive products. As a broad incumbent in the reproductive health pharmaceutical space, it represents the type of large commercial player Eppin Pharma would ultimately partner with or compete against.
Emerging players
- Population Council: The Population Council is a nonprofit research organization that has historically advanced reproductive health technologies including male contraception. While not a direct commercial peer, it operates in the same reproductive health R&D space and overlaps in male contraceptive research.
- Dare Bioscience: Dare Bioscience is a clinical-stage biopharmaceutical company focused on women's reproductive health. While its primary focus is female contraception, it competes for the same overall reproductive health market and investor capital as Eppin Pharma.
Market position
Customer concentration
Eppin Pharma social profiles
Digital presenceEppin Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eppin Pharma leadership team
Management profileNumber of profiles
Eppin Pharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eppin Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eppin Pharma
What does Eppin Pharma do?
Eppin Pharma is developing a novel non-hormonal, orally administered male contraceptive pill intended to provide reversible male birth control without hormonal intervention. The product is in early clinical development, with current activities focused on proof-of-concept studies for safety and feasibility to support future larger efficacy trials and regulatory approval.
Is Eppin Pharma a public or private company?
Eppin Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Eppin Pharma founded?
Eppin Pharma was founded in 2001. It employs 1 to 10 people.
Where is Eppin Pharma based?
Eppin Pharma is headquartered in Durham, United States, in the North America region.
How does Eppin Pharma make money?
One revenue line is on record: pharmaceutical product revenue (future).
Who are Eppin Pharma's main competitors?
Direct peers on record are Contraline, YourChoice Therapeutics and NEXT Life Sciences. Broad incumbents are Evofem Biosciences, Cosette Pharmaceuticals, Bayer (Pharmaceuticals Division), Merck & Co. and Organon. Emerging players are Population Council and Dare Bioscience.
Does Eppin Pharma have an API?
No public API is recorded for Eppin Pharma.
What industry is Eppin Pharma in?
Eppin Pharma's product category is Reproductive Health Pharmaceuticals (Male Contraceptives). Its primary akta.pro industry code is HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 325412 and its SIC code is 2834.